The ability to identify low-level somatic DNA mutations and minority alleles within an excess wild-type sample is becoming essential for characterizing early and posttreatment tumor status in cancer patients. Over the past 2 decades, much research has focused on improving the selectivity of PCR-based technologies for enhancing the detection of minority (mutant) alleles in clinical samples. Routine application in clinical and diagnostic settings requires that these techniques be accurate and cost-effective and require little effort to optimize, perform, and analyze.
A prominent concern confronting clinical and diagnostic applications is the ability to detect clinically significant low-level mutations and minority alleles. The ability to discern mutations is important in many regards, but especially for (a) early cancer detection from tissue biopsies and bodily fluids such as plasma or serum; (b) assessment of residual disease after surgery or radiochemotherapy; (c) disease staging and molecular profiling for prognosis or tailoring therapy to individual patients; and (d) monitoring of therapy outcome and cancer remission/relapse. Efficient detection of cancer-relevant somatic mutations largely depends on the selectivity of the techniques and methods employed. Detection and identification of oncogene and tumor-suppressor gene mutations primarily require analysis of precancerous or cancerous tissue, sputum, urine, stool, and circulating extracellular DNA released in blood. The sample is typically composed of both wild-type and mutant DNA, and the quantity of wildtype DNA often exceeds the mutant DNA contribution. In many cases, wild-type DNA vastly exceeds mutant DNA, making it difficult to detect and identify minority alleles present at extremely low concentrations.
The use of enrichment methods is often beneficial or necessary to increase the mutant concentration to a level at which accurate and precise analysis is feasible. The selectivity of the enrichment and detection methods used must be carefully considered to maintain accuracy. To detect low-level early mutations in tumors or the emergence of resistance mutations (e.g., 10 -3 to 10 -6 mutant to wild-type DNA), both high selectivity and enrichment of minority alleles are required for successful detection and identification. Furthermore, for a particular approach to be used as a routine diagnostic tool, it must achieve a balance of high selectivity and enrichment while maintaining accuracy, convenience, and low cost.
With these guidelines in mind, we reviewed a selection of PCR-based methods developed to preferentially enrich known or unknown mutations present in low concentrations among wild-type DNA. Parsons and Heflich (1 ) and Gocke et al. (2 ) have previously reviewed enrichment methods (also known as "genotypic selection methods"); however, those reviews focused primarily on early methods specifically designed for the enrichment of known point mutations (mutations at predefined DNA positions). Enrichment meth-ods typically segregate by their ability to enrich either known or unknown mutations. The design and development of mutation enrichment methodologies is a much easier task for known mutations than it is for unknown mutations, as sequence data can be used, specific nucleotides can be targeted, and a wider scope of applications are available. As a result, more methods have been developed and modified to preferentially enrich known mutations than unknown mutations. For many cancer-relevant genes, the occurrence of unknown somatic mutations can be very important, and mutation-selectivity is a strong consideration in choosing the appropriate method for routine testing and identification. Selectivity of a mutation detection method refers to the selection of mutation-containing alleles among an excess of wild-type alleles; enrichment refers to a process that increases mutant allele concentration relative to wild-type alleles, such that subsequent mutation detection is facilitated. For purposes of this review, minority allele enrichment methods will be discussed according to their ability to enhance known vs unknown mutations and their degree of selectivity.
MODERATE-TO HIGH-SELECTIVITY METHODS AND ENRICHMENT OF KNOWN MUTATIONS
Many moderate-to high-selectivity PCR methods for known mutations have been developed over the past 2 decades (Table 1) . One of the most widely used approaches relies on the use of 3Ј terminal nucleotide manipulation to enhance allele-specific amplification of a particular nucleotide variant (i.e., mutant or minority allele). Methods such as amplification refractory mutation system (ARMS) 1 (3 ) , allele-specific enzymatic amplification (ASPCR) (4 ), allele-specific amplification (ASA) (5 ), PCR amplification of specific alleles (PASA) (6 ) , and PCR amplification of multiple specific alleles (PAMSA) (7 ) have the ability to enrich minority alleles present among wild-type DNA at concentrations as low as 0.1% to 1%. Generally, these approaches are relatively easy to use and tend to produce results with high accuracy, although selectivity typically remains low to moderate. Increasing the selectivity further by the inclusion of additional nucleotide mismatches toward the 3Ј end is possible, but requires extensive experimentation and optimization. Derivatives of this approach have been developed and include competitive oligonucleotide priming (COP) (8 ) 
a Selectivity is presented as a range representing the commonly achieved and maximum selectivity of mutant detection of the approach. b LM, ligation-mediated; sRT-MELT, surveyor-mediated real-time melting.
PCR (EPCR or ME-PCR)] (9 )
, mismatch amplification mutation assay (MAMA) (10 ) , and mutant allelespecific amplification (MASA) (11 ) . These methods have exhibited similar or higher selectivity and the ability to enrich a single minority allele present among 10 2 (COP and ME-PCR) to 10 5 (MAMA) wild-type alleles. Various combinations of allele-specific PCR with real-time PCR have also been shown to effectively enrich minority alleles with moderate to high selectivity. For example, TaqMAMA (12 ) combines the real-time scoring attributes of TaqMan® probes with the selectivity of the MAMA approach to preferentially enrich and simultaneously identify the nature of a known nucleotide variant. TaqMAMA can enrich and detect an alternate allele when present in an excess of approximately 2 ϫ 10 3 wild-type alleles, although it is questionable if this degree of selectivity can be achieved for all mutation screening targets. Another real-time PCRbased approach, antiprimer quenching-based realtime PCR (aQRT-PCR) (13 ) , uses an allele-specific primer for mutant enrichment, real-time genotyping, and real-time product quantification in a single-step, closed-tube format.
Use of thermostable restriction enzymes that selectively destroy wild-type samples during PCR, thereby enriching the mutation frequency, has also led to methods for genotypic selection [restriction endonuclease-mediated selective PCR (REMS-PCR)] (14 ) . When appropriate restriction endonucleases are not available, artificial introduction of a restriction site (AIRS) RFLP (15 ) can generate an endonuclease recognition sequence by modifying 1 or more nucleotides within the priming region of the wild-type DNA. The selectivity of these approaches was reported to enable detection of 1 mutated cell among 2.5 ϫ 10 3 wild-type alleles (15 ) . In real-time format, the combination of TaqMan assays and allele-specific restriction by an endonuclease has detection selectivity for an allele contribution of 1 in 2.0 ϫ 10 3 wild-type alleles (16 ) . Alternative moderate-to high-selectivity techniques have used physical molecular modifications to allele specificity. For example, peptide nucleic acids (PNAs) (17 ) and locked nucleic acids (LNAs) (18 ) both have increased binding affinities. Through a PCR clamping approach, primers can be replaced by LNA or PNA hybridization probes that are specific for the wild type; both PNAs and LNAs can suppress the amplification of wild-type DNA, allowing for increased amplification of the mutant allele. The use of LNAs in wildtype blocking PCR (WTB-PCR) and of PNAs in K-ras amplification has exhibited the ability to identify mutations among 10 5 wild-type alleles (19, 20 ) , although routine application of these approaches often results in detecting mutants at frequencies of 10 -2 to 10 -3
. Last, the FLAG assay (fluorescent amplicon generation) (21 ) combines REMS-PCR with incorporation of an exceptionally thermostable endonuclease (PspGI) and PNA probes and can be performed in real-time, highthroughput, and closed-tube format. The FLAG assay has demonstrated the ability to detect 1 mutant in 10 3 wild-type DNA. Generally, PNA/LNA-based approaches are attractive, although the time and cost required for optimization may hinder their widespread use.
VERY-HIGH-SELECTIVITY METHODS AND ENRICHMENT OF KNOWN MUTATIONS
Some enrichment methods boast very high selectivity and the ability to preferentially enrich and identify known mutations at extremely low levels. RFLP-PCRbased approaches have proven to be simple and inexpensive in their application as well as highly selective for the enrichment of known mutations. The use of thermostable restriction endonucleases either before PCR amplification or concurrently with PCR has been aggressively applied by performing more than 1 round of enrichment, with the aim to increase digestion and suppression of the wild-type allele, thus preferentially amplifying the mutant type. Several derivatives of this approach have been developed; however, one of the first, the restriction site mutation assay (RSM-PCR) (22 ) , has exhibited the capability to enrich mutants present at 1 mutant per 10 8 wild-type genes (1, 23 ) . The APRIL-ATM method (amplification via primer ligation, at the mutation) (24 ) uses an inverse approach, mutant-specific RFLP, to digest mutant PCR products rather than wild-type products. Subsequently, oligonucleotides are ligated to the digested fragments at the site of the mutation and subjected to a second PCR, thus preferentially enriching the mutant DNA. APRIL-ATM has exhibited high selectivity, with the ability to detect a frequency of 1.6 ϫ 10 -6 mutant alleles among wild-type DNA. Although these RFLP-PCR-based approaches are often advantageous because they are simple in application and low in cost, in some cases they may yield selectivity only on the order of 10 -3 to 10 -4 mutants per wild-type DNA (25 ) . One method that reports very high selectivity and enrichment is based on the combined use of pyrophosphate-activated polymerization (PAP) and ASA (25 ) . PAP-ASA employs an allele-specific oligonucleotide (P*), which is activated by pyrophosphorolysis and DNA polymerization during PCR. A 3Ј-terminal dideoxynucleotide is removed in the presence of pyrophosphate, and the activated P* can then be extended by the DNA polymerase. The authors report that this approach is capable of detecting 1 mutant allele in 10 6 to 10 9 wild-type alleles (25 ) . A bidirectional modification of PAP-ASA (bi-PAP-ASA) (26 ) uses 2 opposing, allele-specific 3Јterminal oligonucleotides (P*) to in-crease selectivity and amplify low-level somatic mutants present among 10 7 to 10 9 wild types (Fig. 1A) . On the other hand, not all reports achieve this high selectivity using pyrophosphorolysis. One recent study used a PAP-based method to detect low level B-RAF in uveal melanomas. The authors were able to detect low-level mutations that were not detectable by Sanger sequencing; however, their evaluation of the technique exhibited a detection limit of 1 mutant among 10 4 wild-type alleles.
PCR of single DNA molecules may also be considered a form of high mutant enrichment. For example, digital PCR (27 ) relies on the amplification of individual molecules of DNA (Fig. 1B) . In the original report (27 ) , DNA template was diluted to distribute approximately 1 molecule of DNA per reaction, thus allowing detection of approximately 1 mutant in 10 3 alleles in numerous parallel PCR reactions. In principle, the more reactions that are performed, the higher the selectivity; in practice, the selectivity is limited by the occurrence of PCR errors. Digital PCR is currently difficult to apply in routine applications with conventional thermocyclers, as it requires the analysis of a very large number of samples to detect mutants occurring at very low frequencies relative to the wild-type DNA. However, the latter assessment may eventually change with the onset of nanofluidics. Bielas and Loeb (28 ) developed [random mutation capture (RMC)], a mu-
Fig. 1. Highly selective PCR-based methods for known and unknown mutation enhancement and identification.
(A) Bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification (bi-PAP-ASA) for high selectivity of known mutations (26 ) . P* is a specifically designed oligonucleotide with a 3Ј-terminal blocker that is activated, but not extended, by pyrophosphorolysis. Downstream and upstream P* contain dideoxy C and G at the 3Ј termini that are specific to the mutant but not the wild type. Efficient amplification of the mutant occurs after pyrophosphorolysis (to remove the 3Ј-terminal ddCMP) and polymerization. Inefficient amplification is denoted by the gray arrows. Nonspecific type I error amplification is rare; type II error is caused by serial mismatch phosphorolysis and misincorporation, which results in the exponential amplification of the mutated product and reduces selectivity. (B) Digital PCR for high selectivity of both known and unknown mutations (27 ) . Genomic DNA is diluted to approximately 1-2 copies per well. The number (N) of required wells varies widely and depends on putative mutant and wild-type concentrations. PCR is performed on each sample well individually. PCR amplicons can be used in many downstream applications such as direct sequencing, pyrosequencing, TaqMan assays, and molecular beacons. tant enrichment method, based on a combination of RSM and digital PCR, that is capable of identifying 1 mutant base among 10 8 wild-type nucleotides. In this interesting, but complex, approach, the mutant phenotype is enriched through biotin-labeled probes and magnetic bead separation. The collected fraction is then subjected to TaqI cleavage to digest remaining wild-type DNA; the final product is diluted to isolate single molecules, and quantitative PCR is performed to amplify the mutant phenotype.
Overall, there are currently several approaches available that report high selectivity and enrichment of known mutations and that are also applicable for routine application. Many of these assays are simple in their methodology and application (ASA-and RFLPbased approaches, for example); however, their selectivity is often not sufficient for enhancement of extremely low-level known mutations. On the other hand, highly selective approaches for detecting known mutations can be time-consuming and difficult to perform, and therefore may not be appropriate for most routine clinical and diagnostic applications. Accordingly, the selection of a technique depends very much on the intended application.
ENRICHMENT OF UNKNOWN MUTATIONS FOLLOWED BY MUTATION SEQUENCING
Traditionally, the identification of unknown mutations has relied on Sanger sequencing analysis; however, sequencing is reliable only for detecting mutant alleles that exist at concentrations above approximately 20% among wild-type DNA (27 ) . This degree of sensitivity is inappropriate for detecting low-level somatic mutations in several situations, such as in premalignant tissues or during early cancer development, posttreatment tissue, or apoptotic and necrotic circulating DNA molecules or for detecting the emergence of resistance mutations in radiochemotherapy-treated tumors. The development of techniques that can be applied to enrich DNA containing unknown mutations that exist at low concentrations relative to the wild-type DNA, followed by sequencing to identify the exact nucleotide change, is thus of high interest. To this end, although there are techniques that perform mutation scanning with higher selectivity relative to sequencing [e.g., chemical cleavage of mismatches (CCM); cleavage of mismatches using endonuclease V (endo V), endo VII, T 4 , MutY, thymine DNA glycosylase (TDG), or coding for endoglucanase I (CEL I) mismatch detection enzymes; high-resolution melting (HRM); and others] the following paragraphs focus specifically on methods that enable nondestructive selection and enrichment of DNA containing unknown mutations, such that they can be followed by sequencing to identify the position and exact nucleotide change.
There are several established approaches to enrich DNA containing unknown mutations via the use of electrophoretic methods of post-PCR products. Among these are heteroduplex analysis (HET) (29 ) , single-strand conformation polymorphism (SSCP) (30 ) , denaturing gradient gel electrophoresis (DGGE) (31 ), constant denaturing capillary electrophoresis (CDCE) (32 ) , and denaturing HPLC (dHPLC) (33 ) . For example, for the commonly used dHPLC method, mutant and wild-type PCR products can be physically separated via their difference in retention times on polycarbonate columns and subsequently collected on a fraction collector. The mutant DNA can thus be preferentially separated, PCR-amplified, and used in downstream applications. The disadvantages of fraction-mediated dHPLC are the requirement for extra steps in the overall procedure, the limited electrophoretic separation between mutant and wild-type alleles for certain mutations, and the required equipment expense. When performed accurately, however, this approach has the ability to enrich the mutant fraction 10-fold, from as little as approximately 5% to as much as approximately 50% (34 ) .
Enzymatic approaches using mismatch-detecting enzymes such as immobilized MutS have also been applied to enrich PCR sequences containing unknown mutations (35 ) . In addition, glycosylases MutY or TDG combined with ligation-mediated PCR have also been reported to selectively enrich mutation-containing sequences (36 ) . Unfortunately, the selectivity of MutS is only modest, whereas MutY and TDG-based approaches are restricted to detecting only a fraction of all possible mutations. In another approach, DNA ligation is combined with endo V (37 ). Endo V detects and cleaves heteroduplex DNA 1 base downstream from the mutation. AK16D DNA ligase is then used to fill in background nicks, increasing assay sensitivity. The second step in this approach uses internally labeled primers to eliminate the endo V cleavage at the 5Ј terminus and selectively amplify cleaved fragments, thus allowing for specific mutant detection and amplification. One approach has recently reported the use of a highly selective enzyme, CEL I (Surveyor), in conjunction with ligation of a primer at the 3ЈOH end of CEL I-digested fragments to enable enrichment-PCR of mutation-containing DNA followed by sequencing (38 ) . This approach detects all mutations and enables sequencing of unknown mutations at levels of 1-5 ϫ 10 -2 mutant-to-wild-type ratio.
The sensitivity of approaches employing mismatch-detecting enzymes is ultimately limited by the selectivity and efficiency of the enzymes used. Compared with restriction endonucleases, the selectivity of any available mismatch detecting enzyme is much inferior. An approach that employs a restriction endonu-clease to perform a highly selective mutation scanning is iFLP (inverse PCR-based amplified RFLP) (39 ) . iFLP combines inverse PCR, RFLP, and dHPLC. DNA is circularized and subsequently digested by TaqI restriction enzyme. Circularized DNA that does not normally contain TaqI recognition sequences is targeted in this approach. Any sequence that has acquired TaqI sites anywhere on the sequence due to a mutation is recognized by the enzyme and converted into doublestranded linear DNA fragments, which can be ligated to TaqI-specific adaptors and PCR-amplified. This method can detect 1 unknown mutant in 10 5 wild-type sequences; however, the technique is time-intensive and can detect only a fraction of all possible mutations.
Despite progress provided in the enrichment of unknown minority alleles by methods based on post-PCR capillary electrophoresis or enzymatic recognition followed by second PCR and sequencing, these methods generally require multistep protocols that can be time-consuming to perform. However, a new technique has recently been developed that removes many difficulties associated with the enrichment of unknown mutations. Coamplification at lower denaturation temperature PCR (COLD-PCR) (40 ) is a single-step method that results in the enhancement of both known and unknown minority alleles during PCR, irrespective of mutation type and position. This approach is based on the observation that, for a given DNA sequence close to a critical denaturation temperature (T c ), the percent denaturation becomes sensitive to the exact DNA sequence, such that even point mutations make a substantial difference. This
Fig. 2. COLD-PCR protocol (40 ). Two forms of COLD-PCR have been developed, Full COLD-PCR (A) and Fast COLD-PCR (B). An example protocol for a 167-bp TP53 amplicon is reviewed here.
(A) Full COLD-PCR has the potential to enrich all possible mutations. Several preliminary rounds of conventional PCR enable an initial buildup of 1 or more target amplicons, then the cycling switches to COLD-PCR. After denaturation at 94°C, the PCR amplicons are incubated (e.g., 70°C for 2-8 min) for reannealing and cross-hybridization. Cross-hybridization of mutant and wild-type alleles forms a mismatch-containing structure (heteroduplex) that has a lower melting temperature than a fullymatched structure (homoduplex). The PCR temperature is next raised to the critical denaturation temperature (T c ) (e.g., 86.5°C) to preferentially denature the heteroduplexed amplicons. The temperature is reduced for primer annealing (e.g., 55°C) and then raised to 72°C to extend the amplicon and preferentially amplify the mutation-containing alleles. (B) Fast COLD-PCR is a simpler cycling that can be performed to enrich for mutations that reduce the melting temperature of the wild-type amplicon. Using the mutant T c , rather than the standard 94°C denaturation temperature, preferentially denatures the lower-T m allele. Fast COLD-PCR does not perform the 70°C incubation step. Fast COLD-PCR amplification and enrichment begins earlier in the cycling than in full COLD-PCR, thus resulting in higher enrichment.
principle is used for mutation enrichment by inducing the formation of heteroduplexes at positions of mutations, during PCR. Thus by using a lower denaturation temperature during PCR, double-stranded DNA (dsDNA) containing mismatches (heteroduplexes) denature first. True homoduplexes have a higher melting temperature (T m ) and denature less than heteroduplexes at the critical denaturation temperature; thus their amplification is relatively suppressed (Fig. 2) . For mutations that tend to lower T m (such as G:CϾT:A or G:CϾA:T), which make up approximately 70% of the encountered mutations, COLD-PCR enriches mutant alleles even without formation of heteroduplexes (Fig. 2) . As a general rule, a substantial enrichment for most COLD-PCR reactions can be obtained by using a T c approximately 1°C lower than the amplicon T m ; for certain sequences, however, fine-tuning of the T c can be beneficial, and an optimal T c can vary 0.5°C to 1.5°C lower than the T m . The T m can be experimentally determined on most real-time thermocyclers by performing a melting curve after PCR. The COLD-PCR principle enables direct PCR from genomic DNA to amplify mutation-containing alleles with a selectivity of up to 100-fold over wild-type alleles. Advantages of COLD-PCR include its simplicity in performance, preferential amplification of mismatch-containing dsDNA containing unknown mutations without the need for lengthy protocols or allelespecific primers, probes, and enzymes, and ability to sequence directly the amplified product. Additionally, COLD-PCR can be used in place of conventional PCR and combined with most existing assays, while it requires essentially no additional cost, time, and labor. COLD-PCR has been used to identify both known and unknown mutations in place of PCR for a variety of techniques such as Sanger sequencing (e.g., Fig. 3A) , pyrosequencing (Fig. 3B) , MALDI-TOF (Fig. 3C) , and TaqMan probe analyses (Fig. 3D) (40 ) . Disadvantages of COLD-PCR include the requirement for precise denaturation temperature control during PCR (to within Ϯ0.3°C), restriction of analyzing sequences smaller than approximately 200 bp, vulnerability to polymerase errors, and variability of the overall mutation enrichment obtained depending on DNA position and nucleotide substitution. COLD-PCR selectivity for point mutations can increase further if subsequent PCR rounds are performed, as has already been shown for unknown deletions (40 ) . As with deep-sequencing approaches that use single-molecule sequencing (41 ), COLD-PCR enrichment of mutations is ultimately limited by polymerase-introduced errors. As newer polymerases with very high fidelity are continuously being improved, however, so are the ultimate enrichment abilities of approaches like COLD-PCR. Ultradeep sequencing following several rounds of COLD-PCR could reveal aspects of cancer biology that are clinically very important (e.g., the origins of resistance to therapy).
In summary, technical developments on many fronts in mutation detection are accumulating at a rapid pace. As knowledge of the biological and clinical impact of low-level mutations in cancer is increasing, the need for further development of methods capable of enhancing low-level minority alleles will continue to grow.
